U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 166

1.
Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice
Mary Esmeralda Fuentes, Xiaoyin Lu, Natasha M. Flores, Simone Hausmann, Pawel K. Mazur
Sci Rep. 2024; 14: 8510. Published online 2024 Apr 12. doi: 10.1038/s41598-024-58874-2
PMCID:
PMC11014914
AbstractArticlePDF–1.7M
2.
Dependency of B-Cell Acute Lymphoblastic Leukemia and Multiple Myeloma Cell Lines on MEN1 Extends beyond MEN1–KMT2A Interaction
Tatjana Magdalena Wolffhardt, Franz Ketzer, Stefano Telese, Thomas Wirth, Alexey Ushmorov
Int J Mol Sci. 2023 Nov; 24(22): 16472. Published online 2023 Nov 17. doi: 10.3390/ijms242216472
PMCID:
PMC10670986
AbstractArticlePDF–6.1M
3.
Epigenetic-focused CRISPR/Cas9 screen identifies (absent, small, or homeotic)2-like protein (ASH2L) as a regulator of glioblastoma cell survival
Ezgi Ozyerli-Goknar, Ezgi Yagmur Kala, Ali Cenk Aksu, Ipek Bulut, Ahmet Cingöz, Sheikh Nizamuddin, Martin Biniossek, Fidan Seker-Polat, Tunc Morova, Can Aztekin, Sonia H. Y. Kung, Hamzah Syed, Nurcan Tuncbag, Mehmet Gönen, Martin Philpott, Adam P. Cribbs, Ceyda Acilan, Nathan A. Lack, Tamer T. Onder, H. T. Marc Timmers, Tugba Bagci-Onder
Cell Commun Signal. 2023; 21: 328. Published online 2023 Nov 16. doi: 10.1186/s12964-023-01335-6
PMCID:
PMC10652464
AbstractArticlePDF–8.0M
4.
Multiple endocrine neoplasia type 1 with Zollinger–Ellison syndrome: clinicopathological analysis of a Japanese family with focus on menin immunohistochemistry
Noriko Kimura, Yasuji Hirata, Nozomu Iwashiro, Hiroshi Kijima, Shinobu Takayasu, Satoshi Yamagata, Satoru Sakihara, Shinya Uchino, Masanori Ohara
Front Endocrinol (Lausanne) 2023; 14: 1221514. Published online 2023 Oct 6. doi: 10.3389/fendo.2023.1221514
PMCID:
PMC10588651
AbstractArticlePDF–6.2M
5.
MEN1 is a regulator of alternative splicing and prevents R-loop-induced genome instability through suppression of RNA polymerase II elongation
Bangming Jin, Jiamei Zhu, Ting Pan, Yunqiao Yang, Li Liang, Yuxia Zhou, Tuo Zhang, Yin Teng, Ziming Wang, Xuyan Wang, Qianting Tian, Bing Guo, Haiyang Li, Tengxiang Chen
Nucleic Acids Res. 2023 Aug 25; 51(15): 7951–7971. Published online 2023 Jul 3. doi: 10.1093/nar/gkad548
PMCID:
PMC10450199
AbstractArticlePDF–2.8M
6.
Clinically Defined Mutations in MEN1 Alter Its Tumor-suppressive Function Through Increased Menin Turnover
Suzann Duan, Sulaiman Sheriff, Uloma B. Elvis-Offiah, Brandon L. Witten, Travis W. Sawyer, Sinju Sundaresan, Tomasz Cierpicki, Jolanta Grembecka, Juanita L. Merchant
Cancer Res Commun. 2023 Jul; 3(7): 1318–1334. Published online 2023 Jul 24. doi: 10.1158/2767-9764.CRC-22-0522
PMCID:
PMC10364643
AbstractArticlePDF–16M
7.
Frequent Germ-Line Mutations of the MEN1, CASR, and HRPT2/CDC73 Genes in Young Patients with Clinically Non-familial Primary Hyperparathyroidism
Lee F. Starker, Tobias Åkerström, William D. Long, Alberto Delgado-Verdugo, Patricia Donovan, Robert Udelsman, Richard P. Lifton, Tobias Carling
Horm Cancer. 2012 Apr; 3(1-2): 44–51. Published online 2011 Dec 21. doi: 10.1007/s12672-011-0100-8
PMCID:
PMC10358143
AbstractArticlePDF–296K
8.
MEN1 PNET Genotype/Phenotype- Is there any advance on predicting or preventing?
Bhavishya Ramamoorthy, Naris Nilubol
Surg Oncol Clin N Am. Author manuscript; available in PMC 2024 Apr 1.
Published in final edited form as: Surg Oncol Clin N Am. 2023 Apr; 32(2): 315–325. doi: 10.1016/j.soc.2022.10.008
PMCID:
PMC10348402
ArticlePDF–330K
9.
Evaluating the role of MEN1 gene expression and its clinical significance in breast cancer patients
Sheersh Massey, Mohammad Aasif Khan, Safia Obaidur Rab, Saad Mustafa, Asifa Khan, Zoya Malik, Rahimunnisa Shaik, Mohit Kumar Verma, SVS Deo, Syed Akhtar Husain
PLoS One. 2023; 18(7): e0288482. Published online 2023 Jul 12. doi: 10.1371/journal.pone.0288482
PMCID:
PMC10337982
AbstractArticlePDF–1.9M
10.
MEN1 mutations mediate clinical resistance to Menin inhibition
Florian Perner, Eytan M. Stein, Daniela V. Wenge, Sukrit Singh, Jeonghyeon Kim, Athina Apazidis, Homa Rahnamoun, Disha Anand, Christian Marinaccio, Charlie Hatton, Yanhe Wen, Richard M. Stone, David Schaller, Shoron Mowla, Wenbin Xiao, Holly A. Gamlen, Aaron J. Stonestrom, Sonali Persaud, Elizabeth Ener, Jevon A. Cutler, John G. Doench, Gerard M. McGeehan, Andrea Volkamer, John D. Chodera, Radosław P. Nowak, Eric S. Fischer, Ross L. Levine, Scott A. Armstrong, Sheng F. Cai
Nature. Author manuscript; available in PMC 2023 Sep 15.
Published in final edited form as: Nature. 2023 Mar; 615(7954): 913–919. Published online 2023 Mar 15. doi: 10.1038/s41586-023-05755-9
PMCID:
PMC10157896
AbstractArticlePDF–4.2M
11.
Казуистические случаи карциномы околощитовидной железы при верифицированной мутации в гене <i>MEN1</i>
С. В. Пылина, Е. И. Ким, Е. В. Бондаренко, Ю. А. Крупинова, А. К. Еремкина, Н. Г. Мокрышева
Probl Endokrinol (Mosk) 2023; 69(1): 15–27. Russian. Published online 2023 Feb 25. doi: 10.14341/probl13176
PMCID:
PMC9978878
AbstractArticlePDF–5.6M
12.
MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors: MEN1 promotes ferroptosis in pancreatic neuroendocrine tumors
Zeng Ye, Haidi Chen, Shunrong Ji, Yuheng Hu, Xin Lou, Wuhu Zhang, Desheng Jing, Guixiong Fan, Yue Zhang, Xuemin Chen, Qifeng Zhuo, Jie Chen, Xiaowu Xu, Xianjun Yu, Jin Xu, Yi Qin, Heli Gao
Acta Biochim Biophys Sin (Shanghai) 2022 Nov; 54(11): 1599–1609. Published online 2022 Nov 8. doi: 10.3724/abbs.2022162
PMCID:
PMC9828289
AbstractArticlePDF–2.3M
13.
The in vivo Interaction Landscape of Histones H3.1 and H3.3
Robert Siddaway, Scott Milos, Étienne Coyaud, Hwa Young Yun, Shahir M. Morcos, Sanja Pajovic, Eric I. Campos, Brian Raught, Cynthia Hawkins
Mol Cell Proteomics. 2022 Oct; 21(10): 100411. Published online 2022 Sep 9. doi: 10.1016/j.mcpro.2022.100411
PMCID:
PMC9540345
AbstractArticlePDF–3.9M
14.
Loss of MEN1 leads to renal fibrosis and decreases HGF‐Adamts5 pathway activity via an epigenetic mechanism
Bangming Jin, Jiamei Zhu, Yuxia Zhou, Li Liang, Yunqiao Yang, Lifen Xu, Tuo Zhang, Po Li, Ting Pan, Bing Guo, Tengxiang Chen, Haiyang Li
Clin Transl Med. 2022 Aug; 12(8): e982. Published online 2022 Aug 15. doi: 10.1002/ctm2.982
PMCID:
PMC9377152
AbstractArticlePDF–21M
15.
Multi-omics analyses of MEN1 missense mutations identify disruption of menin–MLL and menin–JunD interactions as critical requirements for molecular pathogenicity
Koen M. A. Dreijerink, Ezgi Ozyerli-Goknar, Stefanie Koidl, Ewoud J. van der Lelij, Priscilla van den Heuvel, Jeffrey J. Kooijman, Martin L. Biniossek, Kees W. Rodenburg, Sheikh Nizamuddin, H. T. Marc Timmers
Epigenetics Chromatin. 2022; 15: 29. Published online 2022 Aug 9. doi: 10.1186/s13072-022-00461-8
PMCID:
PMC9361535
AbstractArticlePDF–5.7M
16.
Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer
Annamaria Salvati, Viola Melone, Assunta Sellitto, Francesca Rizzo, Roberta Tarallo, Tuula A. Nyman, Giorgio Giurato, Giovanni Nassa, Alessandro Weisz
Breast Cancer Res. 2022; 24: 52. Published online 2022 Jul 18. doi: 10.1186/s13058-022-01547-7
PMCID:
PMC9290241
AbstractArticlePDF–8.2M
17.
Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery
Pierre C. Havugimana, Raghuveera Kumar Goel, Sadhna Phanse, Ahmed Youssef, Dzmitry Padhorny, Sergei Kotelnikov, Dima Kozakov, Andrew Emili
Nat Commun. 2022; 13: 4043. Published online 2022 Jul 13. doi: 10.1038/s41467-022-31809-z
PMCID:
PMC9279285
AbstractArticlePDF–2.5M
18.
OpenCell: proteome-scale endogenous tagging enables the cartography of human cellular organization
Nathan H. Cho, Keith C. Cheveralls, Andreas-David Brunner, Kibeom Kim, André C. Michaelis, Preethi Raghavan, Hirofumi Kobayashi, Laura Savy, Jason Y. Li, Hera Canaj, James Y.S. Kim, Edna M. Stewart, Christian Gnann, Frank McCarthy, Joana P. Cabrera, Rachel M. Brunetti, Bryant B. Chhun, Greg Dingle, Marco Y. Hein, Bo Huang, Shalin B. Mehta, Jonathan S. Weissman, Rafael Gómez-Sjöberg, Daniel N. Itzhak, Loic A. Royer, Matthias Mann, Manuel D. Leonetti
Science. Author manuscript; available in PMC 2022 Sep 11.
Published in final edited form as: Science. 2022 Mar 11; 375(6585): eabi6983. Published online 2022 Mar 11. doi: 10.1126/science.abi6983
PMCID:
PMC9119736
AbstractArticlePDF–3.3M
19.
Multiple endocrine neoplasia type 1 involving both the liver and lung: a case report
Jianlin Lai, Yangyang Huang, Junyi Wu, Hui Cheng, Funan Qiu
World J Surg Oncol. 2022; 20: 151. Published online 2022 May 10. doi: 10.1186/s12957-022-02622-1
PMCID:
PMC9088025
AbstractArticlePDF–4.2M
20.
Loss of MEN1 function impairs DNA repair capability of pancreatic neuroendocrine tumors
Olga Lakiza, Julian Lutze, Alyx Vogle, Jelani Williams, Abde Abukdheir, Paul Miller, Chih-Yi “Andy” Liao, Sean P. Pitroda, Carlos Martinez, Andrea Olivas, Namrata Setia, Stephen J. Kron, Ralph R. Weichselbaum, Xavier M. Keutgen
Endocr Relat Cancer. Author manuscript; available in PMC 2022 Apr 27.
Published in final edited form as: Endocr Relat Cancer. 2022 Mar 21; 29(4): 225–239. Published online 2022 Mar 21. doi: 10.1530/ERC-21-0247
PMCID:
PMC9045673
AbstractArticlePDF–2.9M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center